148 related articles for article (PubMed ID: 38323356)
1. A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.
Wang Y; Gao Z; Zhao W; Li H; Meng X; Li J
Thorac Cancer; 2024 Mar; 15(8):642-653. PubMed ID: 38323356
[TBL] [Abstract][Full Text] [Related]
2. Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
Luo J; Xu L; Zhao L; Cao Y; Pang Q; Wang J; Yuan Z; Wang P
Radiat Oncol; 2017 Feb; 12(1):42. PubMed ID: 28245874
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
Han J; Fu C; Li B
Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
[TBL] [Abstract][Full Text] [Related]
4. Can consolidative thoracic radiotherapy improve outcomes in extensive-disease small cell lung cancer after chemotherapy with complete/near-complete responders?
Kirakli EK; Yilmaz H; Akcay C; Komurcuoglu B; Yilmaz U
J Cancer Res Ther; 2020; 16(4):752-756. PubMed ID: 32930114
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
Yao Y; Li B; Song R; Yang L; Zou B; Wang L
Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
[TBL] [Abstract][Full Text] [Related]
6. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Bayman E; Etiz D; Akcay M; Ak G
Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
[TBL] [Abstract][Full Text] [Related]
7. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M; Higgins KA
Clin Lung Cancer; 2019 Nov; 20(6):484-493.e6. PubMed ID: 31296433
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
[TBL] [Abstract][Full Text] [Related]
10. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
11. Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer.
Xie Z; Liu J; Wu M; Wang X; Lu Y; Han C; Cong L; Li J; Meng X
J Clin Med; 2023 Jun; 12(11):. PubMed ID: 37298023
[TBL] [Abstract][Full Text] [Related]
12. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
[TBL] [Abstract][Full Text] [Related]
13. Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
Perez BA; Kim S; Wang M; Karimi AM; Powell C; Li J; Dilling TJ; Chiappori A; Latifi K; Rose T; Lannon A; MacMillan G; Saller J; Grass GD; Rosenberg S; Gray J; Haura E; Creelan B; Tanvetyanon T; Saltos A; Shafique M; Boyle TA; Schell MJ; Conejo-Garcia JR; Antonia SJ
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):425-435. PubMed ID: 33002543
[TBL] [Abstract][Full Text] [Related]
14. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
[TBL] [Abstract][Full Text] [Related]
15. Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations.
Zheng L; Wang Y; Xu Z; Yang Q; Zhu G; Liao XY; Chen X; Zhu B; Duan Y; Sun J
Oncologist; 2019 Aug; 24(8):1031-e612. PubMed ID: 31040256
[TBL] [Abstract][Full Text] [Related]
16. Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.
Shukuya T; Takahashi T; Harada H; Akamatsu H; Sakaguchi C; Imai H; Ono A; Nakamura Y; Tsuya A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
Anticancer Res; 2012 Feb; 32(2):675-80. PubMed ID: 22287762
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
[TBL] [Abstract][Full Text] [Related]
18. Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database.
Mahmoud O; Kwon D; Greenfield B; Wright JL; Samuels MA
Int J Clin Oncol; 2016 Dec; 21(6):1062-1070. PubMed ID: 27380168
[TBL] [Abstract][Full Text] [Related]
19. Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Zhang L; Xu Y; Shen J; He F; Zhang D; Chen Z; Duan Y; Sun J
Radiat Oncol; 2016 Apr; 11():60. PubMed ID: 27097970
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
Patrice GI; Lester-Coll NH; Yu JB; Amdahl J; Delea TE; Patrice SJ
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):97-106. PubMed ID: 29029885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
